Performance of the Molecular International Prognostic Scoring System (IPSS-M) in Myelodysplastic Syndromes Treated with Hypomethylating Agent-Based Therapy: A Multicenter AnalysisKelly S. Chien, Rami S. Komrokji, Luca Lanino et al.|Blood|2024Cited by 0